UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


---------------

FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported):  February 14, 2011


---------------


LAXAI PHARMA, LTD.

---------------------------------------

(Exact name of Registrant as specified in charter)

 

Israel

 

0-17788

 

N/A

(State of Incorporation)

 

(Commission File No.)

 

(IRS Employer

 

 

 

 

Identification Number)

 

 

 

 

 

8905 Regents Park Dr., Suite 210, Tampa, FL

 

33647

(Address of principal executive offices)

 

(Zip Code)

 

Registrant's telephone number, including area code: (813) 528-6004



(Former name or former address, if changed since last report)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o

Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)


o

Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

  









{A0065646.DOC}



 

 

Item 8.01

Other Events

On February 14, 2011 Laxai Pharma, Ltd. (the Company) and one of its wholly owned subsidiaries OSR Holding Corp. filed for bankruptcy protection under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the Middle District of Florida – Tampa Division.  At this time no receiver has been appointed in the case, and no order of liquidation has been entered.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Date:  February 15, 2011

 

 

 

 

LAXAI PHARMA, LTD.

(Registrant)

 

By:  

/s/ Murty Azzarapu

 

Murty Azzarapu, Authorized Officer






{A0065646.DOC}

2